Our September Briefing Note will cover a variety of topics, including: Introduction to Lucy Hardman, Director at A&M Taxand, proposed changes to basis periods for Income Tax, HM Revenue & Customs’ (“HMRC”) Family Investment Company (“FIC”) team, second self-assessment payment on account reminder for 31 July 2021 and Non-Executive Director Fees in the FTSE 350 and SmallCap - Summer 2021

Alvarez & Marsal's Compensation and Benefits Practice is pleased to share the results of its 2021/2022 Oil and Gas Oilfield Services (OFS) Compensation Report. 

In the latest Tax Notes, A&M's Lewis Greenwald and Brendan Sinnott discuss changes to the U.S. compliance requirements for previously taxed earnings and profits and suggest how to simplify the burden.

Leading global professional services firm Alvarez & Marsal (A&M) has released its latest UAE Banking Pulse for Q2 2021. The report highlights that the top ten UAE banks managed a healthy rebound in profitability and balance sheet metrics.

A&M’s “Barometer of the Post-COVID Healthcare Economy” report unveils 2020 market data and trends of top 25 not-for-profit health systems

Managing Directors Vincent Walden, Rich Goode and Steve Spiegelhatler recently published an article for the Association of Certified Fraud Examiners (ACFE)'s Fraud Magazine titled “Place 'ESG' on Your Radar."

The complex pharmaceutical landscape in Europe — especially in Germany — make financial planning and forecasting a difficult and formidable process. To overcome such challenges, drug manufacturers and other companies in the industry are discovering that financial modeling in health care is crucial to predicting future revenue streams, annual budgets, and winning the drug tender game in socialized medicine.

NHSEI has published its new guidance on provider collaboratives setting out how trusts can work together effectively at scale to transform services, tackle unwarranted variation, and deliver the best care for patients and communities. Managing Director, Schellion Horn sets out some lesson learned and top tips for those looking to set up provider collaborative

HMRC continues to promote its Profit Diversion Compliance Facility (the “PDCF”), with all indicators continuing to point to the Facility being a mainstay in HMRC’s tax collection toolbox, particularly given the pressure on HMRC to cover the public costs of COVID-19.

Whether through a traditional IPO, SPAC acquisition, or direct listing, the transition from private to public company comes with an entirely new set of challenges, including increased regulatory oversight, novel corporate governance issues, and growing stakeholder demands for increased transparency and accountability.

The semiconductor chip shortage is expected to be felt into 2022 as the industry continues to work through production shutdowns and delays. Total vehicle inventory remains depressed and is constraining sales numbers as a result.

COVID-19 increased the demand for patient-centric supply chains, and approvals for high-value, small-patient population medicines are rising. Our experts explore the fundamental implications for pharma operations and its path to recovery.